The aim of the present study was to validate the Glucodayw continuous interstitial ambulatory glucose-monitoring device (AGD) against plasma glucose measured from arterialised venous (AV) and glucose from capillary whole blood (finger prick, FP) in non-diabetic subjects in response to an oral glucose tolerance test. Fifteen healthy overweight men (age 30–49 years, BMI 26–31 kg/m2 ) participated. Glucose levels were measured before, during and after consumption of an oral 75 g glucose load using twelve FP samples and forty-four 1 ml AV blood samples during 180 min. Interstitial glucose was measured via the AGD. Three venous samples for fasting insulin were taken to estimate insulin resistance. Profiles of AGD, AV and FP glucose were generate...
BackgroundManagement of postprandial hyperglycemia is a key aspect in diabetes treatment. We develop...
OBJECTIVE — To compare pre- and postmeal capillary blood glucose concentrations mea-sured at the fin...
OBJECTIVE\u2014To evaluate the accuracy of a new subcutaneous glucose sensor (Glucoday; A. Menarini ...
The aim of the present study was to validate the Glucoday® continuous interstitial ambulatory glucos...
AimsThe oral glucose tolerance test (OGTT) is together with haemoglobin A1c (HbA1c) gold standard fo...
OBJECTIVE — This study investigated whether glucose readings from a sensor sampling in interstitial ...
Continuous glucose monitoring devices measure glucose in interstitial fluid. The devices are effecti...
Evaluation of metabolic control of diabetic people has been classically performed measuring glucose ...
BACKGROUND: The use of an oral glucose tolerance test (OGTT) has been recommended to diagnose type 2...
The abdominal subcutaneous interstitium is easily accessible for monitoring glucose for Diabetes Mel...
Background The aim of the study was to find a simple intravenous glucose tolerance test (IVGTT) that...
Background. The purpose of this study was to investigate the accuracy of the continuously stored dat...
Abstract The present study evaluated the accuracy of interstitial glucose measurements by flash gluc...
Background: Diabetes mellitus is an independent risk factor for cardiovascular disease. Objective: T...
OBJECTIVE — We have examined whether rapid changes in blood glucose (BG) result in clinically releva...
BackgroundManagement of postprandial hyperglycemia is a key aspect in diabetes treatment. We develop...
OBJECTIVE — To compare pre- and postmeal capillary blood glucose concentrations mea-sured at the fin...
OBJECTIVE\u2014To evaluate the accuracy of a new subcutaneous glucose sensor (Glucoday; A. Menarini ...
The aim of the present study was to validate the Glucoday® continuous interstitial ambulatory glucos...
AimsThe oral glucose tolerance test (OGTT) is together with haemoglobin A1c (HbA1c) gold standard fo...
OBJECTIVE — This study investigated whether glucose readings from a sensor sampling in interstitial ...
Continuous glucose monitoring devices measure glucose in interstitial fluid. The devices are effecti...
Evaluation of metabolic control of diabetic people has been classically performed measuring glucose ...
BACKGROUND: The use of an oral glucose tolerance test (OGTT) has been recommended to diagnose type 2...
The abdominal subcutaneous interstitium is easily accessible for monitoring glucose for Diabetes Mel...
Background The aim of the study was to find a simple intravenous glucose tolerance test (IVGTT) that...
Background. The purpose of this study was to investigate the accuracy of the continuously stored dat...
Abstract The present study evaluated the accuracy of interstitial glucose measurements by flash gluc...
Background: Diabetes mellitus is an independent risk factor for cardiovascular disease. Objective: T...
OBJECTIVE — We have examined whether rapid changes in blood glucose (BG) result in clinically releva...
BackgroundManagement of postprandial hyperglycemia is a key aspect in diabetes treatment. We develop...
OBJECTIVE — To compare pre- and postmeal capillary blood glucose concentrations mea-sured at the fin...
OBJECTIVE\u2014To evaluate the accuracy of a new subcutaneous glucose sensor (Glucoday; A. Menarini ...